🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to measure the effect and safety of treatment ...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2024-10-30
Trial ID
NCT06433219
Treatments Being Tested
The purpose of this research study is to see if the combination of study dr...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-11-14
Trial ID
NCT06518564
This is a single sequence 2-period open label study in participants with ad...
Status
Completed
Location
Pharmaceutical Research Associates Magyarország Kutatás - Fejlesztési Kft., Klinikai Farmakológiai Vizsgálóhely
Start Date
2024-03-25
Trial ID
NCT06308263
This is an open-label, multicenter, clinical study conducted in multiple pa...
Status
Active Not Recruiting
Location
Providence Medical Foundation
Start Date
2022-06-07
Trial ID
NCT05396833
Treatments Being Tested
This is an Open-label, multicenter clinical study conducted in two Phases t...
Status
Active Not Recruiting
Location
UCLA Hematology and Oncology - Santa Monica
Start Date
2023-09-13
Trial ID
NCT05882734
Treatments Being Tested
This phase II trial compares tuvusertib in combination with avelumab to tuv...
Status
Active Not Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2024-05-21
Trial ID
NCT05947500
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Active Not Recruiting
Location
NEXT Oncology - PARENT
Start Date
2024-08-07
Trial ID
NCT06421935
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of peposert...
Status
Recruiting
Location
National Cancer Institute Developmental Therapeutics Clinic
Start Date
2024-06-07
Trial ID
NCT05687136
This is an open-label, Phase I, first-in-human (FIH) multicenter, clinical ...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2019-12-20
Trial ID
NCT04170153
This phase I/II trial studies the side effects and best dose of temozolomid...
Status
Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2023-09-28
Trial ID
NCT05691491